My Companies
Notification
Account
Log Out
Login
Sun Pharma will hold a board meeting on 12 October 2026 to consider approving issuance of listed rated unsecured redeemable NCDs up to Rs 15,000 crore via private placement in one or more tranches.
Sun Pharma Licenses Lerodalcibep From LIB Therapeutics For Ex-US China Markets
Sun Pharma Agrees U.S. MFN Pricing For Two-Year Tariff Delay
Sun Pharma Wins Favorable Lipitor Antitrust Ruling In US Appeal